Point72 Hong Kong LTD Spring Works Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$48.97 - $65.46 $76,931 - $102,837	-1,571 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$53.3 - $75.84 $55,911 - $79,556	1,049 Added 200.96%	1,571 $97,000
Q3 2021 Nov 15, 2021	BUY	$62.66 - $88.26 $32,708 - $46,071	522 New	522 $33,000
Q2 2021 Aug 16, 2021	SELL	$67.45 - $85.63 $8,970 - $11,388	-133 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$65.1 - $93.59 $18,944 - $27,234	-291 Reduced 68.63%	133 $10,000
Q4 2020 Feb 16, 2021	BUY	$48.36 - $77.92 $20,504 - $33,038	424 New	424 $31,000

238

69.8M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.6B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.